Collective Family Office’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-119,420
| Closed | -$106K | – | 185 |
|
|
2022
Q4 | $106K | Buy |
119,420
+13,500
| +13% | +$12K | 0.05% | 169 |
|
|
2022
Q3 | $166K | Buy |
105,920
+7,175
| +7% | +$11.2K | 0.08% | 164 |
|
|
2022
Q2 | $198K | Buy |
98,745
+11,735
| +13% | +$23.5K | 0.09% | 181 |
|
|
2022
Q1 | $203K | Buy |
87,010
+19,200
| +28% | +$44.8K | 0.08% | 187 |
|
|
2021
Q4 | $315K | Buy |
67,810
+23,607
| +53% | +$110K | 0.12% | 143 |
|
|
2021
Q3 | $337K | Buy |
44,203
+15,443
| +54% | +$118K | 0.14% | 131 |
|
|
2021
Q2 | $279K | Buy |
28,760
+6,075
| +27% | +$58.9K | 0.12% | 144 |
|
|
2021
Q1 | $188K | Buy |
22,685
+725
| +3% | +$6.01K | 0.09% | 164 |
|
|
2020
Q4 | $150K | Buy |
+21,960
| New | +$150K | 0.08% | 150 |
|